Filing Details
- Accession Number:
- 0001209191-13-007372
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-02-08 16:19:51
- Reporting Period:
- 2013-02-06
- Filing Date:
- 2013-02-08
- Accepted Time:
- 2013-02-08 16:19:51
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1555280 | Zoetis Inc. | ZTS | Pharmaceutical Preparations (2834) | 460696167 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
78003 | Pfizer Inc | 235 East 42Nd Street New York NY 10017 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Acquisiton | 2013-02-06 | 12,915,000 | $0.00 | 12,915,000 | No | 4 | C | Direct | |
Class A Common Stock | Disposition | 2013-02-06 | 99,015,000 | $0.00 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Class A Common Stock | Class B Common Stock | Disposition | 2013-02-06 | 12,915,000 | $0.00 | 12,915,000 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
400,985,000 | No | 4 | C | Direct |
Footnotes
- The Class A Common Stock was acquired pursuant to the conversion of Class B Common Stock in an exempt transaction under the Exchange Act Rule 16b-6(b). The Class B Common Stock was converted into Class A Common Stock on a one-for-one basis and had no exercise or conversion price.
- Pfizer Inc. may be deemed a director of the Issuer on the basis of its relationship with five of the directors of the Issuer.
- Pfizer Inc. disposed of 99,015,000 shares of Class A Common Stock in exchange for outstanding debt obligations of Pfizer Inc. The debt obligations were valued at their fair market value, and the fair market value of the debt obligations exchanged equaled $25.038 per share of Class A Common Stock exchanged.
- Each share of Class B Common Stock held by Pfizer Inc. or one of its subsidiaries will be convertible into one share of Class A Common Stock at any time but will not be convertible if held by any other holder.